Position in STTK
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,172
+$883 QoQ
Shares Held
183,246
+130.9% QoQ
Ownership
0.239%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ACADIAN ASSET MANAGEMENT LLC holds $653,852 across 179 Biotechnology names. STTK ranks #57 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,900,824 | $178,867 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
151,191 | $116,782 | |
| 3 | LEGN |
Legend Biotech Corp
|
1,527,336 | $27,617 | |
| 4 | TBPH |
Theravance Biopharma, Inc.
|
1,276,576 | $20,710 | |
| 5 | RIGL |
Rigel Pharmaceuticals Inc
|
666,426 | $18,009 | |
| 6 | IMCR |
Immunocore Holdings plc
|
501,091 | $15,091 | |
| 7 | PRTA |
Prothena Corp Public Ltd Co
|
1,547,593 | $15,037 | |
| 8 | PBYI |
Puma Biotechnology, Inc.
|
2,041,759 | $13,043 |
All Filings in STTK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,172 | 183,246 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $289 | 79,367 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $785 | 329,288 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $205 | 260,958 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $243 | 257,345 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $242 | 201,658 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2 | 627 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $170 | 44,193 | Shares | Defined | 2024-08-06 | |
| 2022-03-31 | $37,952 | 8,909 | Shares | Defined | 2022-05-12 | |
| No filing history on record for this holder in this stock. | ||||||